Viewing Study NCT06474325



Ignite Creation Date: 2024-07-17 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06474325
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-25
First Post: 2024-06-18

Brief Title: Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA
Sponsor: University of Pittsburgh
Organization: University of Pittsburgh

Study Overview

Official Title: Feasibility and Acceptability of Mobile Mental Health Application for the Improvement of Medication Adherence in Persons With SchizophreniaSZ and Schizoaffective DisorderSZA
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A new mental health application will be developed for persons with schizophrenia and schizoaffective disorder The aim is to look at whether it is feasible to use a mobile health application for improving medication adherence in persons with schizophrenia and schizoaffective disorder and whether it is acceptable to that population
Detailed Description: Many interventions have been tried to improve the medication adherence of patients with schizophrenia Individualized interventions using like setting alarms and using checklists have shown significant improvement in compliance with the medications In the era of mobile applications most of the persons use mobile applications for multiple purposes which have the potential to influence the life of a person in many ways A meta-analysis conducted in 2016 showed that 664 of psychotic patients owned a mobile phone A study conducted in North India found that 844 of patients with severe mental disorders owned a mobile phone So if used properly it can also help in improving the life of a person with SZ

Many mobile applications have been used to improve medication compliance in general But only a few mobile applications have specifically focused the persons with schizophrenia Very few studies have investigated the efficacy of mobile applications to improve medication adherence in patients with schizophrenia This study will be assessing the feasibility of developing a mobile application and using the application for improving compliance of medications in persons with schizophrenia and schizoaffective disorder

Primary aims

To develop a mobile mental health application for the improvement of medication adherence in persons with schizophrenia and schizoaffective disorder
To assess the feasibility and the acceptability of using a mobile mental health application for improving the medication adherence of persons with schizophrenia and schizoaffective disorder

Primary Objectives

To assess the feasibility and the acceptability of using a mobile mental health application for improving the medication adherence of persons with schizophrenia and schizoaffective disorder

Secondary Objective

To compare the Medication adherence rating scale scores before and after using mental health application for improving medication adherence in persons with schizophrenia and schizoaffective disorder

1 Initial screening of the participants will be done by the psychiatrist PI In the Psychiatry OPD
2 Persons with schizophrenia and schizoaffective disorder who are in remissionIn Remission for past 2 months and attending the Psychiatry Outpatient department at Government Medical College Palakkad will be recruited
3 After taking informed consent participants will be assigned into intervention group
4 Pre intervention assessments will be done eg Symptoms the Medication Adherence using relevant scales
5 After the pre-intervention assessment Mobile application will be installed into participants mobile phoneInstruction will be given on the features of the mobile application and how to use it
6 Participants will receive the intervention via mobile application installed to their mobile phone patient will continue to take their regular medications including antipsychotics Intervention via mobile application include psychoeducational videos reminders and virtual rewards and badges for completing the challenges to encourage adherence of medications
7 Duration of intervention will be three months
8 Post-intervention assessment will be done within one week after completion of the intervention eg symptoms the Medication Adherence feedback Acceptance questionnaire

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
D43TW009114 NIH None None